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Valvular heart disease (VHD) which defines as structural 
or functional abnormality of cardiac valve, is a major 
health problem and presence of severe VHD may be the 
important cause of disability, reduced quality of life, cardiac 
dysfunction and premature mortality from cardiovascular 
disease. The etiology of VHD may be congenital, acquired, 
or both. Acquired VHD may be rheumatic or nonrheumatic 
origin. Although the epidemiology of VHD has changed 
in the past few decades, there are still major differences in 
the etiology of VHD between developed and developing 
countries. Degenerative valve disease is regarded as a major 
burden of valvular disease in developed nations (1,2). In 
contrast, rheumatic fever and rheumatic heart disease 
remains the leading cause in developing countries (3-5), 
and previous data estimated that the global prevalence of 
rheumatic heart disease was 15.6–19.6 million and 79% 
people were from less developed countries (6). However, 
research into epidemiology evaluation of VHD is limited 
and the actual incidence of VHD is still unknown in most 
countries because most cases of VHD are chronic and 
often asymptomatic. In the States, the overall prevalence 
of moderate or severe valvular disease is estimated at 2.5% 
with no sex difference, and prevalence increased with age, 
from 0.7% in those aged 18–44 years to 13.3% in those 
aged >75 years (7). Furthermore, mitral regurgitation is the 
most common VHD in the USA, affecting almost 10% of 
the population in the 75 years and older people (7). In the 
Euro Heart Survey program, aortic stenosis was reported as 
the most frequent valve disease (43%), followed by mitral 
regurgitation (32%) and aortic regurgitation (13%) in the 
hospital based VHD (2). 
The data from OxVALVE Population Cohort Study 
reveals the substantial burden of VHD in older people (1). 
This prospective cohort study investigated the epidemiological 
characterist ics of VHD in people aged ≥65 years 
in Oxfordshire, United Kingdom. The participants were 
recruited from five primary care medical centres and 
underwent echocardiography and clinical assessments. 
For the first 2,500 enrolled participants, newly detected 
(predominantly mild) VHD accounted for 51%, and the 
most common valve lesion was aortic sclerosis (34%), 
followed by mitral regurgitation (22%) and aortic 
regurgitation (15%). The authors also reported that the 
total prevalence of clinically moderate or severe VHD was 
11.3% after including subjects with known VHD (identified 
using National Health Service diagnostic codes), and they 
estimated that the prevalence of clinically moderate or 
severe VHD will double before 2050 (from 1.5 million 
in 2015 to 3.3 million in 2056). There are several points 
that merit discussion in this initial report. First, it is an 
important article describing epidemiological characteristics 
dedicated to older people in United Kingdom base on a 
large population and many information were consistent with 
the previous studies in the western countries especially for 
the etiology of VHD (2,7). Importantly, it clearly showed 
that VHD is common and the prevalence of VHD increased 
linearly with age due to the predominantly degenerative 
etiologies, which have caught our much attention for 
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providing appropriate management for these patients in 
clinical practice. 
However, OxVALVE Population Cohort Study reported 
that aortic sclerosis was the most common abnormality 
and accounted for 34% population of newly identified 
VHD, which differs from the previous studies (2,7). Mitral 
regurgitation and aortic stenosis were respectively reported 
as the most common VHD in the USA (7) and European 
countries (2). This difference can be explained that aortic 
sclerosis was a degenerative VHD and related to aging, 
genetic and environmental factors. Further, aortic valve 
calcification usually occurs in the elderly and previous study 
found that patients with aortic sclerosis had a low rate of 
progression to clinical aortic stenosis (1.8–1.9% per year) (8). 
Moreover, this difference also demonstrated that there was a 
dramatic decline in the incidence of rheumatic heart disease 
and a significant increase in the incidence of degenerative 
etiology in developed countries.
Furthermore, the paper reported a closed association 
between socioeconomic class status and VHD. In 
particular, the prevalence of VHD in the most deprived 
people was higher and approximately double that in the 
least deprived people. We agree with the authors that the 
lower socioeconomic class status may have the potential 
contribution to the development of the valvular disease. On 
the other hand, poor living conditions such as malnutrition 
and overcrowding may be the underlying mechanism 
increasing the incidence of the valvular disease. One 
previous study has demonstrated that mortality of rheumatic 
heart disease was significantly higher among patients living 
in low-income countries (4), which indicates that there may 
be a close correlation between lower socioeconomic class 
status and morbidity or mortality in VHD. In addition, 
lower socioeconomic status has also been reported to 
be associated with lower risk-adjusted quality of life for 
patients undergoing cardiac surgery (9). Therefore, poorly 
social and economic status should also be considered as the 
risk factor leading to VHD.
Another important finding of this large-scale study was 
that participants with atrial fibrillation had much higher 
prevalence of VHD than those in sinus rhythm (newly 
diagnosed VHD 67.9% vs. 32.1%; clinically moderate or 
severe VHD 21.1% vs. 5.7%). Actually, there is a strong 
association between atrial fibrillation and valvular disease, 
and patients with combined atrial fibrillation and valve 
disease are very common in clinical practice. Previous 
studies have demonstrated that the prevalence of rheumatic 
VHD in patients with atrial fibrillation ranged from 21% 
in South Africa (10) to 66.3% in Ethiopia (11). People who 
have atrial fibrillation and valvular disease are generally 
older and have more comorbidities, thus attention must be 
paid not only to the anticoagulation and intervention, but 
also to their overall treatment. 
The present report from the OxVALVE Population 
Cohort Study gave a lot of new information regarding 
VHD in elderly patients; nonetheless certain areas need 
further clarification. It is clear that over half of the studied 
population had VHD, however the clinical outcome in 
these patients, in particular to patients with only mild 
degree of valvular disease, compared to those without VHD 
is uncertain. In addition, the progression of the severity of 
VHD will need further evaluation in order to define the 
optimal timing of repeating echocardiography to assess for 
the progression of valvular status. Because of the emergence 
of various transcatheter-based intervention, a growing 
population of elderly patients will be eligible for these 
corrective procedures and therefore the aforementioned 
issues need to be addressed. Finally, the current data is 
only limited to developed countries and information from 
developing countries will also require further evaluation. 
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